BioCentury | Dec 8, 2017
Clinical News

Sunovion gets FDA approval for Lonhala Magnair COPD treatment

...Starnberg, Germany) developed the eFlow system. Sumitomo gained the product through its 2012 acquisition of Elevation Pharmaceuticals Inc....
...Pharma Co. Ltd. (Tokyo:4506), Osaka, Japan Product: Lonhala Magnair glycopyrrolate (SUN-101/eFlow) (formerly EP-101) Business: Pulmonary Allison Johnson SUN-101 Elevation Pharmaceuticals Inc. Pari...
BioCentury | Aug 16, 2017
Clinical News

FDA accepts Sunovion's SUN-101 resubmission for COPD

...GmbH (Starnberg, Germany) developed the eFlow system. Sumitomo gained SUN-101 through its 2012 acquisition of Elevation Pharmaceuticals Inc....
BioCentury | Jun 1, 2017
Clinical News

Sunovion receives CRL for COPD candidate SUN-101

...GmbH (Starnberg, Germany) developed the eFlow system. Sumitomo gained SUN-101 through its 2012 acquisition of Elevation Pharmaceuticals Inc....
BioCentury | May 30, 2017
Clinical News

FDA issues CRL for Sunovion’s COPD therapy

...GmbH (Starnberg, Germany) developed the eFlow system. Sumitomo gained SUN-101 through its 2012 acquisition of Elevation Pharmaceuticals Inc....
BioCentury | Oct 13, 2016
Company News

FDA reviewing Sunovion's COPD therapy

...Starnberg, Germany) developed the eFlow nebulizer system. Sumitomo gained SUN-101 through its 2012 acquisition of Elevation Pharmaceuticals Inc....
BioCentury | Apr 28, 2016
Clinical News

Sunovion's SUN-101 meets in COPD Phase IIIs

...Starnberg, Germany) developed the eFlow nebulizer system. Sumitomo gained SUN-101 through its 2012 acquisition of Elevation Pharmaceuticals Inc....
BioCentury | Jan 7, 2013
Finance

Novo's public moves

...In September 2012, the Sunovion Pharmaceuticals Inc. subsidiary of Dainippon Sumitomo Pharma Co. Ltd. acquired Elevation Pharmaceuticals Inc....
BioCentury | Sep 10, 2012
Company News

Elevation Pharmaceuticals, Dainippon Sumitomo deal

...inhaled formulation of glycopyrrolate, a long-acting muscarinic antagonist (LAMA), by 2016 (see BioCentury, Sept. 3). Elevation Pharmaceuticals Inc....
BioCentury | Sep 3, 2012
Company News

Elevation Pharmaceuticals, Dainippon Sumitomo deal

...delivered using an eFlow electronic nebulizer from Pari GmbH (Starnberg, Germany) (see BioCentury, May 21). Elevation Pharmaceuticals Inc....
BioCentury | Aug 31, 2012
Company News

Sunovion to acquire Elevation

...The Sunovion Pharmaceuticals Inc. subsidiary of Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506; Osaka:4506) will acquire Elevation Pharmaceuticals Inc....
Items per page:
1 - 10 of 21
BioCentury | Dec 8, 2017
Clinical News

Sunovion gets FDA approval for Lonhala Magnair COPD treatment

...Starnberg, Germany) developed the eFlow system. Sumitomo gained the product through its 2012 acquisition of Elevation Pharmaceuticals Inc....
...Pharma Co. Ltd. (Tokyo:4506), Osaka, Japan Product: Lonhala Magnair glycopyrrolate (SUN-101/eFlow) (formerly EP-101) Business: Pulmonary Allison Johnson SUN-101 Elevation Pharmaceuticals Inc. Pari...
BioCentury | Aug 16, 2017
Clinical News

FDA accepts Sunovion's SUN-101 resubmission for COPD

...GmbH (Starnberg, Germany) developed the eFlow system. Sumitomo gained SUN-101 through its 2012 acquisition of Elevation Pharmaceuticals Inc....
BioCentury | Jun 1, 2017
Clinical News

Sunovion receives CRL for COPD candidate SUN-101

...GmbH (Starnberg, Germany) developed the eFlow system. Sumitomo gained SUN-101 through its 2012 acquisition of Elevation Pharmaceuticals Inc....
BioCentury | May 30, 2017
Clinical News

FDA issues CRL for Sunovion’s COPD therapy

...GmbH (Starnberg, Germany) developed the eFlow system. Sumitomo gained SUN-101 through its 2012 acquisition of Elevation Pharmaceuticals Inc....
BioCentury | Oct 13, 2016
Company News

FDA reviewing Sunovion's COPD therapy

...Starnberg, Germany) developed the eFlow nebulizer system. Sumitomo gained SUN-101 through its 2012 acquisition of Elevation Pharmaceuticals Inc....
BioCentury | Apr 28, 2016
Clinical News

Sunovion's SUN-101 meets in COPD Phase IIIs

...Starnberg, Germany) developed the eFlow nebulizer system. Sumitomo gained SUN-101 through its 2012 acquisition of Elevation Pharmaceuticals Inc....
BioCentury | Jan 7, 2013
Finance

Novo's public moves

...In September 2012, the Sunovion Pharmaceuticals Inc. subsidiary of Dainippon Sumitomo Pharma Co. Ltd. acquired Elevation Pharmaceuticals Inc....
BioCentury | Sep 10, 2012
Company News

Elevation Pharmaceuticals, Dainippon Sumitomo deal

...inhaled formulation of glycopyrrolate, a long-acting muscarinic antagonist (LAMA), by 2016 (see BioCentury, Sept. 3). Elevation Pharmaceuticals Inc....
BioCentury | Sep 3, 2012
Company News

Elevation Pharmaceuticals, Dainippon Sumitomo deal

...delivered using an eFlow electronic nebulizer from Pari GmbH (Starnberg, Germany) (see BioCentury, May 21). Elevation Pharmaceuticals Inc....
BioCentury | Aug 31, 2012
Company News

Sunovion to acquire Elevation

...The Sunovion Pharmaceuticals Inc. subsidiary of Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506; Osaka:4506) will acquire Elevation Pharmaceuticals Inc....
Items per page:
1 - 10 of 21